Human Insulin (Medium Duration of Action) Tender - 137687828

Procurement Summary

Country: Ukraine

Summary: Human Insulin (Medium Duration of Action), Suspension for Injections, 100 U/Ml, Bottle, 10 Ml Each; Tranexamic Acid Solution for Injection, 100 Mg/Ml in 5 Ml; Cefepime, Powder for Injection 1.0; Acetylsal...

Deadline: 14 Mar 2026

Posting Date: 13 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 137687828

Document Ref. No.: UA-2026-03-11-012090-a

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: UAH 1736756.44

CPV Classification

33600000 - Pharmaceutical products
33610000 - Medicinal products for the alimentary tract and metabolism
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33690000 - Various medicinal products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Human insulin (Medium duration of action), suspension for injections, 100 U/ml, bottle, 10 ml each; Tranexamic acid solution for injection, 100 mg/ml in 5 ml; Cefepime, powder for injection 1.0; Acetylsalicylic acid tablets 75 mg; Water for injections ampoules for 5 ml; Enalapril 10 mg tablets; Epinephrine 1.82 mg/ml, solution for injection, ampoule; Clopidogrel, film-coated tablets, 75 mg each; Moxifloxacin solution for infusions, 400 mg/250 ml, 250 ml each; Ofloxacin, solution for infusions, 2 mg/ml, 100 ml each; Paracetamol solution for infusions 10 mg/ml 100 ml; Ceftriaxone, powder for injections of 1 g; Fluconazole, solution for infusions, 2 mg/ml, 100 ml each; Metronidazole, solution for infusions, 5 mg/ml per 100 ml; Cefotaxime, powder for injections of 1 g; Amoxicillin and clavulanate acid, powder for injections/infusions 1.2 g; Tropicamide eye drops 10 mg/ml, 10 ml No. 1; Oseltamivir tablets/capsules of 75 mg Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to INN: Acetylsalicylic acid, Classification according to ATX: B01AC06, Release form, Dose of active substance: 75 mg, Packaging type: Blister, Vial, Strip; Oseltamivir tablets/capsules of 75 mg Oseltamivir, J05AH02, Capsules, Tablets, 75 mg, Blister Name Classifier and its corresponding code Quantity/Unit of measure Place of delivery Date of delivery Name DK 021:2015: 33600000-6 — Pharmaceutical products Classification according to INN: Acetylsalicylic acid, Classification according to ATX: B01AC06, Release form, Dose of active substance: 75 mg, Type packaging: Blister, Vial, Strip; Oseltamivir tablets/capsules of 75 mgOseltamivir, J05AH02, Capsules, Tablets, 75 mg, Blister Name Classifier and its corresponding code Quantity/Unit of measurement Place of supply Date of supply Name Human insulin (Medium duration of action), suspension for injection, 100 Units/ml, bottle, 10 ml each, Tranexamic acid solution for injection...

Documents

 Tender Notice